Bristol-Myers Squibb: The Winning Streak Continues (BMY)
24 days 18 hours 42 minutes ago - Financial News NetwFork Online - 52-week High-Lows via Comtex

Bristol-Myers Squibb (NYSE:BMY) traded today at a new 52-week high of $42.87. So far today approximately 7.2 million shares have been exchanged, as compared to an average 30-day volume of 10.1 million shares.

Bristol-Myers Squibb (NYSE:BMY) defies analysts with a current price ($42.39) 13.7% above its average consensus price target of $36.57. The stock should find initial support at its 50-day moving average (MA) of $38.96 and further support at its 200-day MA of $34.92.

In the past 52 weeks, shares of Bristol-Myers Squibb have traded between a low of $30.64 and a high of $42.87 and are now at $42.39, which is 38% above that low price. The 200-day and 50-day moving averages have moved 0.24% higher and 0.73% higher over the past week, respectively.

Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures and sells pharmaceutical and nutritional products. The Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders.

---------------------------------------------------------------------------------------------

Financial News Network Online (FNNO) is a leading provider of digital financial news content for distribution on the web. You can count on FNNO to bring you the latest market news, earnings reports, analyst comments, economic data reports and more. Visit http://www.fnno.com today.